• About
    • Company Profile
    • Company History
    • People
    • Privacy Policy
  • Clinical Need
  • Technology
    • Hu-PHEC
    • CDX Antibodies
    • HEMO-CAR-T
    • Advanced Hematopoietic Chimeras
  • Pipeline
  • Investors
    • Company Information & Prospectuses
      • Board of Directors
      • Corporate Governance
      • Corporate Advisers
      • Registrar & FAQs
    • Shareholder Information
    • Share Data & Announcements
    • Annual & Half Year Reports
    • Broker Coverage
    • Media Coverage
    • Videos & Presentations
  • News
  • Join Us
  • Contact

Annual & Half Year Reports

2022

2022 Half Year Report

Proxy Form (2022 AGM)

AGM Notice (2022 AGM)

2021

2021 Annual Report (print version)

2021 Annual Report (ESEF)

2021 Annual Report (official version)

2021 Half Year Report

Proxy Form (2021 AGM)

AGM Notice (2021 AGM)

2020

2020 Annual Report (print version)

2020 Annual Report (official version)

Proxy Form (January 2021 General Meeting)

General Meeting Notice (January 2021)

Circular & General Meeting Notice (December 2020 – withdrawn)

2020 Half Year Report

Proxy Form (2020 AGM)

AGM Notice (2020 AGM)

2019

2019 Annual Report

2019 Half Year Report

Proxy Form (2019 AGM)

AGM Notice (2019 AGM)

2018

2018 Annual Report

2018 Half Year Report

Proxy Form (2018 AGM)

AGM Notice (2018 AGM)

2017

2017 Annual Report (Hemogenyx Pharmaceuticals)

Interim Report for the period ended 30 June 2017 (Silver Falcon)

2016

2016 Annual Report (Silver Falcon)

Interim Report for the period ended 30 June 2016 (Silver Falcon)

2015

2015 Annual Report (Silver Falcon)

Interim Report for the period ended 31 August 2015 (Silver Falcon)

About Us

Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases

UK Headquarters

6th Floor, 60 Gracechurch Street, London, EC3V 0HR, United Kingdom

Research Facility

1361 Amsterdam Ave., Suite 320, New York, NY 10027, USA

Contact Us

© Hemogenyx Pharmaceuticals plc 2017--2023. All rights reserved. Hemogenyx Pharmaceuticals plc is registered in England and Wales as company number 08401609 at 6th Floor, 60 Gracechurch Street, London, EC3V 0HR, United Kingdom. LEI 2138008L93GYU5GN6179.
We set cookies on your computer by default to help make this website better. By continuing to use this site you are agreeing to our use of cookies. You can change your cookie settings at any time.
ACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT